Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Glenda Wickstrom
Re: Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Related publications
Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke
Expert Opinion on Drug Delivery
Pharmaceutical Science
Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?
Neurology International
Neurology
Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke
The Egyptian Journal of Hospital Medicine
Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry
PLoS ONE
Multidisciplinary
Genome Response to Tissue Plasminogen Activator in Experimental Ischemic Stroke
BMC Genomics
Biotechnology
Genetics
Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Predictors of Systemic Inflammatory Response Syndrome in Ischemic Stroke Undergoing Systemic Thrombolysis With Intravenous Tissue Plasminogen Activator
Journal of Stroke and Cerebrovascular Diseases
Surgery
Neurology
Cardiovascular Medicine
Rehabilitation
Cardiology
Early Changes of Tissue Perfusion After Tissue Plasminogen Activator in Hyperacute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing